Co-Therapy of Silymarin and Vitamin E Attenuates Doxorubicin-Induced Hepatotoxicity in Rats by Mitigating Oxidative Damage and Preserving Hepatic Architecture. Tikrit Journal of Pharmaceutical Sciences, [S. l.], v. 20, n. 1, p. 20–32, 2026. DOI: 10.25130/tjphs.2026.20.1.3.20.32. Disponível em: https://tjphs.tu.edu.iq/index.php/j/article/view/689. Acesso em: 8 aug. 2026.